MRI 導引神經外科消融市場規模、佔有率、成長分析（按產品、適應症、最終用途和地區）- 產業預測，2025 年至 2032 年

MRI 導引的神經外科消融市場規模預計在 2023 年達到 5.9 億美元，並從 2024 年的 6.3543 億美元成長到 2032 年的 11.5025 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 7.7%。

由於神經系統疾病和腦腫瘤的增加以及向微創手術技術的轉變，神經外科市場正在大幅擴張。這些先進的手術使用專門的設備來最大限度地減少組織損傷和手術風險，由於恢復時間更快、切口更少而受到患者的青睞。倫敦大學學院開發的一種新型癌症治療方法利用 MRI 精確摧毀腫瘤而不損害健康組織，這種創新技術使治療更加有效。此外，高解析度 MRI 技術的進步使得手術過程中可以進行即時視覺化，從而提高安全性和患者的治療效果。美國癌症協會預測，2023 年將有近 24,810 例腦和神經系統癌症新病例，對這些微創治療的需求可能會持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

MRI 導引神經外科消融市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• MRI 導引雷射消熔系統
• MRI 導引射頻消融系統
• MRI 導引聚焦超音波系統
• 配件

MRI 導引神經外科消融市場規模（按適應症和複合年成長率）（2025-2032）

• 市場概況
• 瘤
• 癲癇
• 疼痛管理
• 血管畸形

MRI 導引神經外科消融市場規模（按最終用途和複合年成長率分類）（2025-2032 年）

• 市場概況
• 醫院
• 診所
• 門診手術中心

MRI 導引神經外科消融市場規模和複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Monteris Medical（美國）
• InSightec Ltd.（以色列）
• Profound Medical Corp.（加拿大）
• 美敦力公司 (愛爾蘭)
• 波士頓科學公司（美國）
• AngioDynamics Inc.（美國）
• ClearPoint Neuro, Inc.（美國）
• Elekta AB（瑞典）
• Accuray Incorporated（美國）
• Brainlab AG（德國）
• 瓦里安醫療系統（美國）
• 雅培實驗室（美國）
• 西門子醫療股份公司（德國）
• 飛利浦醫療保健（荷蘭）
• GE醫療（美國）

結論和建議

MRI-Guided Neurosurgical Ablation Market size was valued at USD 590.0 million in 2023 and is poised to grow from USD 635.43 million in 2024 to USD 1150.25 million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The market for neurosurgery is expanding significantly, driven by an increase in nervous system disorders and brain tumors, alongside a shift toward minimally invasive surgical techniques. These advanced procedures, which minimize tissue injury and surgical risks through specialized equipment, are preferred by patients due to their expedited recovery times and fewer incisions. Innovations, such as a new cancer treatment developed at UCL that utilizes MRI for precise tumor destruction, are further enhancing treatment efficacy without harming healthy tissue. Additionally, advancements in high-resolution MRI technology enable real-time visualization during surgeries, improving safety and patient outcomes. As the American Cancer Society projects nearly 24,810 new cases of brain and nervous system cancers in 2023, the demand for these less invasive treatments will continue to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Mri-Guided Neurosurgical Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Mri-Guided Neurosurgical Ablation Market Segments Analysis

Global MRI-Guided Neurosurgical Ablation Market is segmented by Product, Indication, End-Use and region. Based on Product, the market is segmented into MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories. Based on Indication, the market is segmented into Tumors, Epilepsy, Pain Management and Vascular Malformations. Based on End-Use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Mri-Guided Neurosurgical Ablation Market

The MRI-Guided Neurosurgical Ablation market is primarily fueled by the rising incidence of neurological disorders. These conditions, which significantly affect the nervous system, often lead to severe or even life-threatening consequences for patients. As such, there is an escalating need for effective treatment options. Innovative therapies, particularly MRI-guided neurosurgical ablation, have gained traction due to their precision and effectiveness in treating complex neurological issues. This growing acceptance of advanced, minimally invasive techniques represents a pivotal shift in the management of neurological diseases, further driving the market demand for MRI-guided neurosurgical ablation solutions.

Restraints in the Mri-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market faces significant restraints primarily due to insurance and reimbursement challenges. Although these innovative procedures provide promising treatment options for patients with neurological disorders, inconsistencies in insurance coverage and reimbursement policies can create substantial financial barriers. Many insurance providers may not offer comprehensive coverage for MRI-guided neurosurgical ablation, resulting in patients having to pay a considerable portion of the costs themselves, which may deter them from pursuing these treatments. Furthermore, the absence of standardized reimbursement protocols across different regions and insurance plans exacerbates these financial challenges, leading to varied access for patients and potentially hindering the widespread adoption of this advanced technology. Addressing these issues is essential to facilitate fair access to MRI-guided neurosurgical ablation and encourage its integration into standard healthcare practices.

Market Trends of the Mri-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market is witnessing a significant shift towards patient-centric care, which is revolutionizing treatment paradigms by prioritizing individual patient needs and preferences. This trend underscores the importance of tailoring procedures to match specific patient conditions, enhancing the effectiveness of minimally invasive treatments. By fostering collaborative decision-making, patients become active participants in their healthcare journey, leading to improved satisfaction and outcomes. As this patient-centered model gains momentum, it aligns with the broader movement towards personalized and responsive healthcare services in neurosurgery, thereby positioning MRI-guided ablation as a cornerstone of modern, individualized patient care solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global MRI-Guided Neurosurgical Ablation Market Size by Product & CAGR (2025-2032)

• Market Overview
• MRI Guided Laser Ablation Systems
• MRI Guided RF Ablation Systems
• MRI Guided Focused Ultrasound Systems
• Accessories

Global MRI-Guided Neurosurgical Ablation Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Tumors
• Epilepsy
• Pain Management
• Vascular Malformations

Global MRI-Guided Neurosurgical Ablation Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size & CAGR (2025-2032)

• North America (Product, Indication, End-Use)
  • US
  • Canada
• Europe (Product, Indication, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Monteris Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ClearPoint Neuro, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations